P/E ratio for Stryker Corporation (SYK)
P/E ratio as of September 2023 (TTM): 39.9
According to Stryker Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 39.8993. At the end of 2021 the company had a P/E ratio of 50.6.
P/E ratio history for Stryker Corporation from 2001 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | 50.6 | -11.91% |
| 2020 | 57.4 | 52.25% |
| 2019 | 37.7 | 128.19% |
| 2018 | 16.5 | -70.88% |
| 2017 | 56.7 | 108.77% |
| 2016 | 27.2 | 11.66% |
| 2015 | 24.3 | -58.99% |
| 2014 | 59.3 | 109.23% |
| 2013 | 28.4 | 76.38% |
| 2012 | 16.1 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Medtronic MDT | 29.5 | -26.04% | 🇮🇪 Ireland |
 Baxter BAX | -6.66 | -116.69% | 🇺🇸 USA |
 Boston Scientific BSX | 89.3 | 123.90% | 🇺🇸 USA |
 Edwards Lifesciences EW | 30.7 | -23.09% | 🇺🇸 USA |
 Waters Corporation WAT | 23.6 | -40.81% | 🇺🇸 USA |
 Integra LifeSciences IART | 24.4 | -38.83% | 🇺🇸 USA |
 Smith & Nephew
SNN | 22.6 | -43.35% | 🇬🇧 UK |
 Owens & Minor
OMI | -12.1 | -130.31% | 🇺🇸 USA |
 Hill-Rom HRC | N/A | N/A | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.